Link To Us Link To Us

Bookmark Us Bookmark Us

Supplier Login Supplier Login

Linscott's Directory of Immunological & Biological Reagents
CAYMAN CHEMICAL COMPANY
 (http://www.caymanchem.com)

CAYMAN CHEMICAL COMPANY

1180 East Ellsworth Road

Ann Arbor MI 48108

Phone: (734) 971-3335

Phone: (800) 364-9897 (USA & Canada only)

Fax: (734) 971-3640

Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com

Website: http://www.caymanchem.com

 
 
CAYMAN CHEMICAL COMPANY Products - Page 194 of 691
Page 194 of 691
Records 4,826 - 4,850 of 17,261
Name Description Size Catalog #
alpha-Asarone A component of certain essential oils used in traditional Chinese herbal medicine; carcinogenic, neuroprotective, and radioprotective in mice when given at 50 mg/kg; inhibits HMG-CoA reductase (IC50 = 3 mM); inhibits CYP2D6 and CYP3A4 (IC50 = 55.2 and 65.2 µg/ml, respectively) 5 g 11681-5
alpha-Asarone A component of certain essential oils used in traditional Chinese herbal medicine; carcinogenic, neuroprotective, and radioprotective in mice when given at 50 mg/kg; inhibits HMG-CoA reductase (IC50 = 3 mM); inhibits CYP2D6 and CYP3A4 (IC50 = 55.2 and 65.2 µg/ml, respectively) 500 mg 11681-500
alpha-CEHC alpha-CEHC is the major urinary metabolite of alpha-tocopherol following vitamin E supplementation.{9177} The concentration of alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon supplementation with RRR-alpha-tocopherol. About one-third of the alpha-CEHC circulating in the blood is present as a glucuronide conjugate.{14208} alpha-CEHC was only excreted when a threshold concentration of 7-9 µmol alpha-tocopherol/g total lipid in plasma was exceeded. Therefore, excretion of alpha-CEHC may be considered to be a marker of optimum vitamin E intake.{14209} 1 mg 10007705-1
alpha-CEHC alpha-CEHC is the major urinary metabolite of alpha-tocopherol following vitamin E supplementation.{9177} The concentration of alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon supplementation with RRR-alpha-tocopherol. About one-third of the alpha-CEHC circulating in the blood is present as a glucuronide conjugate.{14208} alpha-CEHC was only excreted when a threshold concentration of 7-9 µmol alpha-tocopherol/g total lipid in plasma was exceeded. Therefore, excretion of alpha-CEHC may be considered to be a marker of optimum vitamin E intake.{14209} 10 mg 10007705-10
alpha-CEHC alpha-CEHC is the major urinary metabolite of alpha-tocopherol following vitamin E supplementation.{9177} The concentration of alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon supplementation with RRR-alpha-tocopherol. About one-third of the alpha-CEHC circulating in the blood is present as a glucuronide conjugate.{14208} alpha-CEHC was only excreted when a threshold concentration of 7-9 µmol alpha-tocopherol/g total lipid in plasma was exceeded. Therefore, excretion of alpha-CEHC may be considered to be a marker of optimum vitamin E intake.{14209} 25 mg 10007705-25
alpha-CEHC alpha-CEHC is the major urinary metabolite of alpha-tocopherol following vitamin E supplementation.{9177} The concentration of alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon supplementation with RRR-alpha-tocopherol. About one-third of the alpha-CEHC circulating in the blood is present as a glucuronide conjugate.{14208} alpha-CEHC was only excreted when a threshold concentration of 7-9 µmol alpha-tocopherol/g total lipid in plasma was exceeded. Therefore, excretion of alpha-CEHC may be considered to be a marker of optimum vitamin E intake.{14209} 5 mg 10007705-5
alpha-Crystallin (A Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.4 kDa 10 µg 15152-10
alpha-Crystallin (A Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.4 kDa 25 µg 15152-25
alpha-Crystallin (A Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.4 kDa 5 µg 15152-5
alpha-Crystallin (B Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.6 kDa 10 µg 15153-10
alpha-Crystallin (B Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.6 kDa 25 µg 15153-25
alpha-Crystallin (B Chain) (human recombinant) Source: Recombinant N-terminal His-tagged protein expressed in E. coli • Mr: 22.6 kDa 5 µg 15153-5
alpha-Ethylaminopentiophenone (hydrochloride) A substituted cathinone that is an analog to ethcathinone, differing by having propyl rather than methyl at the alpha position 10 mg 14280-10
alpha-Ethylaminopentiophenone (hydrochloride) A substituted cathinone that is an analog to ethcathinone, differing by having propyl rather than methyl at the alpha position 5 mg 14280-5
alpha-Ethylaminopentiophenone (hydrochloride) A substituted cathinone that is an analog to ethcathinone, differing by having propyl rather than methyl at the alpha position 50 mg 14280-50
alpha-Ethyltryptamine A tryptamine derivative that has been reported to be a potent releaser of serotonin as well as an inhibitor of monoamine oxidase; generalizes to DOM (ED50 = 0.4 mg/kg) and PMMA (ED50 = 0.7 mg/kg) in tests of stimulus generalization in rats; intended for forensic and research applications 10 mg 14653-10
alpha-Ethyltryptamine A tryptamine derivative that has been reported to be a potent releaser of serotonin as well as an inhibitor of monoamine oxidase; generalizes to DOM (ED50 = 0.4 mg/kg) and PMMA (ED50 = 0.7 mg/kg) in tests of stimulus generalization in rats; intended for forensic and research applications 25 mg 14653-25
alpha-Ethyltryptamine A tryptamine derivative that has been reported to be a potent releaser of serotonin as well as an inhibitor of monoamine oxidase; generalizes to DOM (ED50 = 0.4 mg/kg) and PMMA (ED50 = 0.7 mg/kg) in tests of stimulus generalization in rats; intended for forensic and research applications 5 mg 14653-5
alpha-Ethyltryptamine (exempt preparation) A tryptamine derivative that has been reported to be a potent releaser of serotonin as well as an inhibitor of monoamine oxidase; generalizes to DOM (ED50 = 0.4 mg/kg) and PMMA (ED50 = 0.7 mg/kg) in tests of stimulus generalization in rats; intended for forensic and research applications 1 mg 15671-1
alpha-Guanidinoglutaric Acid A linear mixed-type inhibitor of nNOS having a Ki value of 2.69 µM; normally present in small quantities in the cerebral cortex of cats with increased levels following seizure 10 mg 80340-10
alpha-Guanidinoglutaric Acid A linear mixed-type inhibitor of nNOS having a Ki value of 2.69 µM; normally present in small quantities in the cerebral cortex of cats with increased levels following seizure 100 mg 80340-100
alpha-Guanidinoglutaric Acid A linear mixed-type inhibitor of nNOS having a Ki value of 2.69 µM; normally present in small quantities in the cerebral cortex of cats with increased levels following seizure 5 mg 80340-5
alpha-Guanidinoglutaric Acid A linear mixed-type inhibitor of nNOS having a Ki value of 2.69 µM; normally present in small quantities in the cerebral cortex of cats with increased levels following seizure 50 mg 80340-50
alpha-hydroxy Farnesyl Phosphonic Acid alpha-hydroxy Farnesyl phosphonic acid is a nonhydrolyzable analog of farnesyl pyrophosphate which acts as a competitive inhibitor of farnesyl protein transferase (FPTase).{1199,5456} At concentrations greater than 1 µM, alpha-hydroxy farnesyl phosphonic acid inhibits the processing of Ras in Ha-ras-transformed NIH3T3 cells.{1196} 1 mg 63420-1
alpha-hydroxy Farnesyl Phosphonic Acid alpha-hydroxy Farnesyl phosphonic acid is a nonhydrolyzable analog of farnesyl pyrophosphate which acts as a competitive inhibitor of farnesyl protein transferase (FPTase).{1199,5456} At concentrations greater than 1 µM, alpha-hydroxy farnesyl phosphonic acid inhibits the processing of Ras in Ha-ras-transformed NIH3T3 cells.{1196} 10 mg 63420-10
© 1980 - 2014 Linscott's Directory, Linscott's USA. All rights reserved.